Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
95. Lynch A, Byers T, Emlen W, et al. Association of antibodies to beta(2)-glycoprotein 1 with pregnancy loss and pregnancy-induced hyperten-
SHS-OOO4.qxd 21.11.2006 16:56 Page 247
ГЛАВА 8. Клиническое значение антифосфолипидных антител
sion: A prospective study in low-risk pregnancy. Obstet Gynecol 1999; 93: 193.
96. Lee RM, Emlen, W, Scott, JR, et al. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 1999; 181: 642.
97. Yasuda M, Takakuwa, K, Tokunaga, A, Tanaka, K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86: 555.
98. Lima F, Khamashta MA, Buchanan, NM, et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheu-matol 1996; 14:131.
99. Branch DW, Silver, RM Blackwell, JL, et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614.
100. Schei, B, Ostensen, M, Moen, T, et al. Can maternal antiphospholipid antibodies predict the birth of a small-for-gestational age child? Acta Obstet Gynecol Scand 1995; 74: 425.
101. Out HJ, Bruinse HW, Christiaens GC, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 167: 26.
102. Montaruli B, Borchiellini A, Tamponi G, et al. Factor V Arg506->Gln mutation in patients with antiphospholipid antibodies. Lupus 1996; 5: 303.
103. Silver RM, Draper ML, Scott JR, et al. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet Gynecol 1994; 83: 372.
104. Lynch A, Marlar R, Murphy J, et al. Anti-phospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994; 120: 470.
105. Pattison NS, Chamley LW, McKay EJ, et al. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100: 909.
106. Alsulyman OM, Castro, MA, Zuckerman, E, et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphos-pholipid syndrome. Obstet Gynecol 1996; 88: 644.
107. Branch D W, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001; 184:825.
108. American College of Obstetricians and Gynecologists. Antiphospholipid syndrome. ACOG educational bulletin 244. ACOG 1998; Washington, DC.
109. Galli M. Should we include anti-pro-thrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000; 15: 101—105.
110. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus ery-thematosus. Clin Immunol Immunopathol 1996; 80: 16—22.
111. D'Angelo A, Safa O, Crippa L, Garlando A, Sabbadini M, Vigano' D'Angelo S. Relationship of lupus anticoagulant, anticardi-olipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA syndrome. Thromb Haemost 1997; 78: 967—8.
112. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997; 77: 486—91.
113. Swadzba J, De Clerck L, Stevens W, Bridts C, van Cotthem K, Musial J, et al. Anti-cardiolipin, anti-beta(2)-glycoprotein I, antipro-thrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24: 1710—5.
114. Bertolaccini M, Atsumi T, Khamashta M, Amengual O, Hughes G. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 1998; 25: 1104—8.
115. Guerin J, Smith O, White B, Sweetman G, Feighery C, Jackson J. Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders. Br J Haematol 1998; 102: 896—902.
116. Inanc M, Donohoe S, Ravirajan C, Radway-Bright E, Mackie I, Machin S, et al. Anti-beta2-glycoprotein I, anti prothrombin and anticardiolipin antibodies in a longitudinal study
SHS-OOO4.qxd 21.11.2006 16:56 Page 248
Насонов Е.Л. Антифосфолипидный синдром.
of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 1998; 37: 1089—94.
117. Sorice M, Pittoni V, Circella A, et al. Anti-prothrombin but not pure anticardiolipin antibodies are associated with the clinical features of the antiphospholipid antibodies syndrome. Thromb Haemost 1998; 80: 713—715.
118. Lakos G, Kiss E, Regeczy N, et al. Anti-prothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune disease. J Rheumatol 2000; 27: 924—929.
119. Munoz-Rodriguez F, Reverter J, Font J, et al. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2000; 85: 632—637.
